Patents Assigned to The University Hospital
  • Publication number: 20230211009
    Abstract: A method for producing exosomes in a large-scale by using a cyclic tensile bioreactor to stimulate cells to release exosomes. In addition, the exosome having an anti-HLA-G protein specific for cancer is used as a delivery vehicle to deliver therapeutic agents for treating cancer.
    Type: Application
    Filed: December 2, 2022
    Publication date: July 6, 2023
    Applicants: CHINA MEDICAL UNIVERSITY, China Medical University Hospital, Shine-On Biomedical Co., Ltd.
    Inventors: Yi-Wen Chen, Der-Yang Cho, Hsin-Yuan Fang, Ming-You Shie, Chih-Ming Pan, Kai-Wen Kan, Cheng-Yu Chen, Min-Hua Yu, Shao-Chih Chiu
  • Patent number: 11690727
    Abstract: The present disclosure relates to an artificial ankle joint tibial component and, more particularly, to an artificial ankle joint tibial component of an implant that is implanted into a body, the implant including: a body part having a contact surface in contact with a resected surface of a distal end of a tibia of a joint and a joint surface facing a joint; and a fixing part formed to extend a predetermined length upwards from the contact surface, wherein the fixing part is configured as a single body formed to extent a predetermined length upwards from the center in the front area of the contact surface and includes a wing extending to one side, and wherein the wing includes at least one posterior wing that extends at a predetermined angle relative to an AP line, thereby preventing stress from being concentrated on one wing to avoid a fracture thereof and increasing the contact area between a bone and an implant to strengthen fixing force, prevent rotation, and disperse stress, so that bone resorption aroun
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: July 4, 2023
    Assignees: CORENTEC CO., LTD., CHONNAM NATIONAL UNIVERSITY HOSPITAL, INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
    Inventors: Keun-Bae Lee, Tae-Jin Shin
  • Patent number: 11690761
    Abstract: Systems, devices, and methods for treating a glaucomatous eye are provided. An amount of pulsed laser energy is delivered to the pars plana of the eye by a hand-holdable device which comprises a hand-holdable elongate member and a contact member disposed on an end of the elongate member. A contact surface of the contact member is placed in direct contact with the eye so that a reference edge of the contact member aligns with the limbus and a treatment axis defined by the elongate member is angularly offset from the optical axis of the eye. The amount of pulsed laser energy delivered is insufficient to effect therapeutic photocoagulation but is sufficient to increase uveoscleral outflow so as to maintain a reduction from pre-laser treatment intraocular pressure. Amounts of pulsed laser energy will be transmitted to a circumferential series of tissue regions of the eye.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: July 4, 2023
    Assignees: IRIDEX Corporation, National University Hospital (Singapore) PTE LTD, National University of Singapore
    Inventors: Paul T. K. Chew, David M. Buzawa, Giorgio Dorin
  • Patent number: 11685784
    Abstract: The present disclosure provides an anti-immune-checkpoint nanobody that specifically binds to a programmed cell death ligand 1. The present disclosure also provides the nucleic acid sequence of the anti-immune-checkpoint nanobody, use of the anti-immune-checkpoint nanobody for treating cancer and immune-related disorders, and a method for detecting expression levels of PD-L1.
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: June 27, 2023
    Assignee: CHINA MEDICAL UNIVERSITY HOSPITAL
    Inventors: Der-Yang Cho, Shao-Chih Chiu, Shi-Wei Huang, Chih-Ming Pan, Mei-Chih Chen, Yu-Chuan Lin, Yeh Chen
  • Patent number: 11667974
    Abstract: The present invention provides methods for the diagnosing, monitoring and prognostication of primary and secondary cardiac disorders in a subject based on lncRNA expression. The invention also provides methods for predicting heart failure after myocardial infarction, and differenciation of Ischemic versus non-ischemic Heart Failure. The assessment/quantification of these lncRNAs may also be used as a marker for monitoring drug-induced cardiac toxicities and for the assessment of cardiac involvement during systemic diseases and others disorders/toxicities impacting cardiac function. These lncRNAs are cardiac tissue enriched and may be involved in different cardiac pathophysiological events and represent a potential target for therapeutical approaches.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: June 6, 2023
    Assignees: FIRALIS SA, LUXEMBOURG INSTITUTE OF HEALTH, THE UNIVERSITY HOSPITAL OF LAUSANNE, THE CARDINAL STEFA WUSZYNSKI INSTITUTE OF CARDIOLOGY
    Inventors: Hueseyin Firat, Sabrina Danilin, Yvan Devaux, Lu Zhang, Przemyslaw Leszek, Eric Schordan, Samir Ounzain, Thierry Pedrazzini
  • Publication number: 20230165855
    Abstract: New uses of Cyclo-HisPro (CHP) or a salt thereof for lowering blood pressure are disclosed. More specifically, the present invention relates to a pharmaceutical composition for lowering blood pressure, containing CHP or a salt thereof, and a functional health food composition containing CHP or a salt thereof; a method for lowering blood pressure using CHP or a salt thereof; a use of CHP or a salt thereof in the manufacture of antihypertensive agents; a pharmaceutical composition or a functional health food, for preventing or treating hypertension or complications thereof, containing CHP or a salt thereof; a method for preventing or treating hypertension or complications thereof by using CHP or a salt thereof; and a use of CHP or a salt thereof in the manufacture of a medicament for preventing or treating hypertension or complications thereof.
    Type: Application
    Filed: March 19, 2021
    Publication date: June 1, 2023
    Applicants: NOVMETAPHARMA CO., LTD., SEOUL NATIONAL UNIVERSITY HOSPITAL, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Hoe Yune JUNG, Heon Jong LEE, Yon Su KIM, Seung Hee YANG
  • Publication number: 20230159601
    Abstract: The present invention relates to a pharmaceutical composition and the like for lowering blood cholesterol, preventing or treating cardiovascular diseases and reducing inflammation, containing, as an active ingredient, an inhibitor of binding between CAP1 and PCSK9, an inhibitor of binding between CAP1 and resistin, or a CAP1 gene expression inhibitor. The present invention can lower the level of blood LDL-cholesterol by inhibiting the binding of CAP1 and PCSK9, the binding of CAP1 and resistin or the expression of a CAP1 gene. Therefore, the present invention can be effectively used as a pharmaceutical composition and the like for treating abnormal blood cholesterol levels and various cardiovascular diseases caused thereby, such as dyslipidemia, stroke, arteriosclerosis, and the like, and for inhibiting inflammation.
    Type: Application
    Filed: August 14, 2020
    Publication date: May 25, 2023
    Applicant: SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Hyo-Soo KIM, Hyun-Duk JANG
  • Patent number: 11651588
    Abstract: Disclosed are an object detection method and a convolution neural network. The method is performed through hierarchical architecture of the CNN and includes extracting groups of augmented feature maps from an input image through a backbone and two other groups of feature maps, identifying positive and negative samples with an IOU-based sampling scheme to be proposals for foreground and background through a proposal-sampling classifier, mapping the proposals to regions on the groups of augmented feature maps through the region proposal module, pooling the regions to fixed scale feature maps based on ROI aligning, fusing the fixed scale feature maps, and flattening the fused feature maps to generate an ROI feature vector through an ROI aligner for object classification and box regression. Because extracted features in the groups of augmented feature maps range from spatially-rich features to semantically-rich features, enhanced performance in object classification and box regression can be secured.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: May 16, 2023
    Assignees: NATIONAL TAIWAN UNIVERSITY HOSPITAL
    Inventors: Chao-Yuan Yeh, Wen-Chien Chou, Cheng-Kun Yang
  • Publication number: 20230148371
    Abstract: The present disclosure relates to a method for detecting and/or quantitatively assessing cardiac dyssynchrony of a subject based on at least one medical imaging scan showing at least part of the myocardium of the subject’s heart, in particular mechanical cardiac dyssynchrony. The medical imaging scan may provide a plurality of values of a predefined myocardial deformation parameter of said part of the myocardium. In a preferred embodiment the method comprises the steps of 1) determining a myocardial deformation deviation between pairs of myocardial deformation parameter values selected from the myocardium of substantially opposite parts of a cardiac chamber, and 2) calculating the cardiac dyssynchrony of the subject based on said myocardial deformation deviation.
    Type: Application
    Filed: October 13, 2022
    Publication date: May 11, 2023
    Applicant: Region Nordjylland, Aalborg University Hospital
    Inventor: Tomas Zaremba
  • Patent number: 11642015
    Abstract: A sinus entering endoscope according to an embodiment of the present invention comprises: a body including a plurality of operation parts; an insertion part extending from the front end of the body to be inserted into the sinus through the nasal cavity, and having at least one working channel; and an applicator load part which is disposed in the body and on which a plurality of applicators which can selectively enter through the working channel can be mounted.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: May 9, 2023
    Assignee: SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Chae Seo Rhee, Sung Woo Cho
  • Patent number: 11646099
    Abstract: In embodiments of the invention, the invention provides a method for distinguishing between lymphoma types based on gene expression measurements. In embodiments, the invention distinguishes between PMBCL and DLBCL based on gene expression signatures, and can further distinguish between DLBCL subtypes. In embodiments of the invention, the distinctions are used in methods of treatment.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: May 9, 2023
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, British Columbia Cancer Agency, Mayo Foundation for Medical Education and Research, Julius-Maximilians-University of Würzburg, Boatd of Regents of the University of Nebraska, Oslo University Hospital HF, Hospital Clinic de Barcelona, Universitat de Barceloa, Institut D'Investigacions Biomédiques Pi I Sunyer (IDIBAPS), Robert Bosch Gesellschaft feuer medizinische Forshung mbH, Oregon Health & Science University, City of Hope, The Cleveland Clinic Foundation
    Inventors: Louis M. Staudt, Christian Steidl, Anja Mottok, George W. Wright, David William Scott, Lisa M. Rimsza, Andreas Rosenwald, Randy Gascoyne, Timothy Greiner, Dennis Weisenburger, Erlend B. Smeland, Jan Delabie, Elias Campo Guerri, German Ott, Rita Braziel, Elaine S. Jaffe, Kai Fu, Wing C. Chan, Joo Song, James R. Cook
  • Patent number: 11638519
    Abstract: A system for monitoring a volume of a bladder during a surgical procedure. The system includes one or more processors; and a memory that is communicatively coupled to the one or more processors and stores one or more sequences of instructions, which when executed by one or more processors causes steps to be performed comprising: receiving information of a maximum volume of the bladder before the surgical procedure; receiving one or more ultrasound images from an ultrasonic scanner; based on the one or more ultrasound images, determining a volume of the bladder; comparing a maximum volume of the bladder to the determined volume of the bladder; and responsive to a difference between the maximum volume and determine volume of the bladder exceeding a threshold, issuing a warning associated with the difference.
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: May 2, 2023
    Assignee: SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Seung-June Oh, Hyoun-Joong Kong
  • Publication number: 20230128432
    Abstract: Disclosed are an object detection method and a convolution neural network. The method is performed through hierarchical architecture of the CNN and includes extracting groups of augmented feature maps from an input image through a backbone and two other groups of feature maps, identifying positive and negative samples with an IOU-based sampling scheme to be proposals for foreground and background through a proposal-sampling classifier, mapping the proposals to regions on the groups of augmented feature maps through the region proposal module, pooling the regions to fixed scale feature maps based on ROI aligning, fusing the fixed scale feature maps, and flattening the fused feature maps to generate an ROI feature vector through an ROI aligner for object classification and box regression. Because extracted features in the groups of augmented feature maps range from spatially-rich features to semantically-rich features, enhanced performance in object classification and box regression can be secured.
    Type: Application
    Filed: June 5, 2020
    Publication date: April 27, 2023
    Applicants: AETHERAI IP HOLDING LLC, NATIONAL TAIWAN UNIVERSITY HOSPITAL
    Inventors: Chao-Yuan YEH, Wen-Chien CHOU, Cheng-Kun YANG
  • Publication number: 20230128338
    Abstract: An apparatus for imaging examination of cells on a surface of living tissue using moxifloxacin includes: a light source emitting light towards living tissue stained with moxifloxacin; a photographing unit photographing the living tissue subjected to fluorescence excitation by the light emitted from the light source; a lens unit controlling the light emitted from the light source or a fluorescence path of moxifloxacin excited by the light; an objective lens controlling a focus of the photographing unit; an active lens disposed between the objective lens and the photographing unit and changing a focal position on the living tissue; and an image generator performing image processing of a cell image of the living tissue photographed by the photographing unit to generate an in-focus image, in which the entirety of the cell image is in focus.
    Type: Application
    Filed: January 24, 2022
    Publication date: April 27, 2023
    Applicants: POSTECH Research and Business Development Foundation, SEOUL NATIONAL UNIVERSITY HOSPITAL, UNIVERSITY INDUSTRY FOUNDATION, YONSEI UNIVERSITY WONJU CAMPUS
    Inventors: Ki Hean KIM, Jung Bin LEE, Seong Han KIM, Chang Ho YOON, Sejung Yang
  • Publication number: 20230119563
    Abstract: There is provided a method of providing information about prognosis after cardiac arrest. The method includes the steps of: calculating biological information based on a signal relating to a hemoglobin concentration measured from a cerebral region of a subject to be measured; and providing the information about the prognosis after cardiac arrest of the subject with reference to the calculated biological information and a biomarker relating to the prognosis after cardiac arrest measured from a blood of the subject.
    Type: Application
    Filed: March 5, 2021
    Publication date: April 20, 2023
    Applicants: SEOUL NATIONAL UNIVERSITY HOSPITAL, KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY, OBE LAB., INC.
    Inventors: Sang Bae KO, Tae Jung KIM, Hyeon Min BAE, Jong Kwan CHOI, Jae Myoung KIM
  • Publication number: 20230105273
    Abstract: The present disclosure relates to a novel compound or a salt thereof, a composition for detecting cysteine, a fluorescent probe, and a composition for diagnosing cancer, which contain the same, a method for detecting cysteine, a method for providing information for diagnosing cancer, and a method for producing the novel compound. According to the present disclosure, there may be provided a method of synthesizing and purifying a fluorescent probe for cysteine detection and applying the same to diagnose cervical cancer by detecting cysteine in human urine.
    Type: Application
    Filed: October 28, 2021
    Publication date: April 6, 2023
    Applicants: Industry-Academic Cooperation Group of Kyung Hee University, SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Do Kyoung Kim, Chang Wook Jeong, Jong Min An
  • Patent number: 11597125
    Abstract: Disclosed is a dip-coating method as a method of coating an outer surface of a target mold including steps of: preparing and putting a supporting liquid in a container; applying a coating material to the target mold; dipping the target mold in the supporting liquid; shaking the target mold surrounded by the coating material in the supporting liquid; curing the coating material surrounding the target mold in the supporting liquid; and taking out the coated target mold from the supporting liquid.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: March 7, 2023
    Assignees: POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION, KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL
    Inventors: Joonwon Kim, Seong Hyeon Kim, Dong-Hun Kang, Jaechan Park, Jongkyeong Lim, A-Reum Kim
  • Publication number: 20230066166
    Abstract: The disclosure provides an eye state assessment method and an electronic device. The method includes: obtaining an optic disc image area from a first fundus photography and generating multiple optic cup-to-disc ratio assessment results by multiple first models based on the optic disc image area; obtaining a first assessment result of an eye based on the optic cup-to-disc ratio assessment results; performing multiple data augmentation operations on the first fundus photography to generate multiple second fundus photographies; generating multiple retinal nerve fiber layer (RNFL) defect assessment results by multiple second models based on the second fundus photographies; obtaining a second assessment result of the eye based on the RNFL defect assessment results; and obtaining an optic nerve assessment result of the eye based on the first assessment result and the second assessment result.
    Type: Application
    Filed: October 21, 2021
    Publication date: March 2, 2023
    Applicants: Acer Incorporated, National Taiwan University Hospital
    Inventors: Yi-Jin Huang, Chien-Hung Li, Wei-Hao Chang, Hung-Sheng Hsu, Ming-Chi Kuo, Jehn-Yu Huang
  • Publication number: 20230061211
    Abstract: Disclosed are an artificial prosthesis and a method for manufacturing same. The artificial prosthesis includes a surface having a pattern formed thereon, the pattern comprising straight line shapes aligned in parallel with each other, and has the effect of reducing inflammation in a region implanted with the prosthesis, and effectively reducing capsular contracture side effects.
    Type: Application
    Filed: September 24, 2020
    Publication date: March 2, 2023
    Applicant: Seoul National University Hospital
    Inventors: Chan Yeong Heo, Sun-Young Nam, Byung-Ho Shin
  • Patent number: 11590275
    Abstract: A catheter for treatment of a defect internal of a human or animal body. The catheter may comprise a tube adapted for insertion into the body; an applicator disposed within and moveable relative to the tube; and a porous medium attached to the applicator; wherein the porous medium is capable of fitting inside the tube, whereby the applicator can be controlled at a proximal end of the tube to deploy the porous medium from a distal end of the tube so as to treat the defect.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: February 28, 2023
    Assignees: Cambridge Enterprise Limited, Cambridge University Hospitals NHS Foundation Trust
    Inventors: Andrew Hindmarsh, Thomas Stone, Daniel Marsden, Pierre Lao-Sirieix